Header
Header
Article

Oxford Genetics signs licensing agreement with Aldevron to market lentiviral packaging plasmids



Oxford Genetics, a leading innovator of biopharmaceutical technologies, has signed a licensing agreement with world-class service organization, Aldevron to bring to market a standardized range of its plasmids for lentiviral manufacture.

Source link

Back to top button